Cathy Maes

719 citations

13 papers · 441 · h-index 10

Impact in

Epidemiology top 10%
- Influenza Virus Research Studies
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
Virology top 10%

Papers in

Epidemiology 12
- Pneumonia and Respiratory Infections 5
- Respiratory viral infections research 5
- Influenza Virus Research Studies 4
Infectious Diseases 5
- Viral gastroenteritis research and epidemiology 2

Co-authors: Geert Leroux‐Roels (12 shared papers)Fien De Boever (7 shared papers)Emmanuel Hanon (2 shared papers)François Roman (2 shared papers)Isabel Leroux‐Roels (3 shared papers)Mamadou Dramé (2 shared papers)Paul Gillard (1 shared paper)Julie Willekens (2 shared papers)
Journals: Vaccine (5 papers)Clinical and Vaccine Immunology (2 papers)Clinical Infectious Diseases (1 paper)Frontiers in Immunology (1 paper)Vaccines (1 paper)
Partner nations: Belgium United States United Kingdom

In The Last Decade

Cathy Maes

12 papers receiving 429 citations

Peers

Countries citing papers authored by Cathy Maes

Since Specialization

Citations

This map shows the geographic impact of Cathy Maes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Maes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Maes more than expected).

Fields of papers citing papers by Cathy Maes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Maes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Maes. The network helps show where Cathy Maes may publish in the future.

Co-authors

The 25 scholars most cited alongside Cathy Maes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cathy Maes Line = papers co-authored together Cathy Maes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study Vaccine ·Isabel Leroux‐Roels, François Roman, Sheron Forgus, Cathy Maes, Fien De Boever, Mamadou Dramé, Paul Gillard, Robbert van der Most, Marcelle Van Mechelen, Emmanuel Hanon, Geert Leroux‐Roels	2009	114
2	Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes PLoS ONE ·Geert Leroux‐Roels, Cathy Maes, Frédéric Clément, Frank van Engelenburg, Marieke van den Dobbelsteen, Michael Adler, Mario Amacker, Lucia Lopalco, Morgane Bomsel, Anick Chalifour, Sylvain Fleury	2013	59
3	Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study Vaccine ·Geert Leroux‐Roels, Cathy Maes, Fien De Boever, Magali Traskine, J. Rüggeberg, Dorota Borys	2014	55
4	A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women Vaccine ·Geert Leroux‐Roels, Cathy Maes, Julie Willekens, Fien De Boever, Richard de Rooij, Leah Martell, Lisa Bedell, Frederick Wittke, Karen S. Slobod, Peter Dull	2016	50
5	Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials Clinical and Vaccine Immunology ·François Roman, Frédéric Clément, Walthère Dewé, Karl Walravens, Cathy Maes, Julie Willekens, Fien De Boever, Emmanuel Hanon, Geert Leroux‐Roels	2011	44
6	Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study Vaccine ·Geert Leroux‐Roels, Fien De Boever, Cathy Maes, Thi Lien-Anh Nguyên, Sherryl Baker, Antonio López	2019	27
7	Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4–6 Years After a First Dose: Results From a Phase 2 Trial Clinical Infectious Diseases ·Geert Leroux‐Roels, Zourab Bebia, Cathy Maes, Annelies Aerssens, Fien De Boever, Luca Grassano, Giada Buffi, Immaculada Margarit, Annette Karsten, Stephen Cho, Karen S. Slobod, Bartholomew Corsaro, Ouzama Henry	2019	22
8	Randomized Trial of the Immunogenicity and Safety of the Hepatitis B Vaccine Given in an Accelerated Schedule Coadministered with the Human Papillomavirus Type 16/18 AS04-Adjuvanted Cervical Cancer Vaccine Clinical and Vaccine Immunology ·Geert Leroux‐Roels, Edwige Haelterman, Cathy Maes, Jack Lévy, Fien De Boever, Laurent Licini, Marie-Pierre David, Kurt Dobbelaere, Dominique Descamps	2011	18
9	A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine Frontiers in Immunology ·Isabel Leroux‐Roels, Cathy Maes, Jasper Joye, Bart Jacobs, Franziska Jarczowski, André Diessner, Yorick Janssens, Gwenn Waerlop, Kirsi Tamminen, Suvi Heinimäki, Vesna Blazevic, Geert Leroux‐Roels, Victor Klimyuk, Hiroshi Adachi, Kazuyuki Hiruta, Frank Thieme	2022	17
10	Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50 years of age: Results from a phase III, randomized, non-inferiority trial Vaccine ·Opokua Ofori‐Anyinam, Geert Leroux‐Roels, Mamadou Dramé, Annelies Aerssens, Cathy Maes, Arshad Amanullah, Anne Schuind, Ping Li, Varsha Jain, Bruce L. Innis	2017	17
11	Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine Vaccines ·Isabel Leroux‐Roels, Jacques Bruhwyler, Lilli Stergiou, Mark Sumeray, Jasper Joye, Cathy Maes, Paul‐Henri Lambert, Geert Leroux‐Roels	2023	9
12	Pregnancy has a minimal impact on the acute transcriptional signature to vaccination npj Vaccines ·John S. Tregoning, January Weiner, Deniz Cizmeci, Danielle Hake, Jeroen Maertzdorf, Stefan H. E. Kaufmann, Geert Leroux‐Roels, Cathy Maes, Annelies Aerssens, Anna Calvert, Christine E. Jones	2020	8
13	IMMUNE REACTIVITY OF MYCOBACTERIUM BOVIS (STRAIN BCG) AND MYCOBACTERIUM VACCAE M Rennou, Cathy Maes, H.H. Maes, Roland Maes, A R Hadi Zadeh Tasbiti, Sh. Yari, Ali Karimi, Shamsodin Niknami, A R Bahrehmand	2004	1

About Cathy Maes

Cathy Maes is a scholar working on Epidemiology, Infectious Diseases, Immunology, Public Health, Environmental and Occupational Health and Genetics, having authored 13 papers that have together received 441 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (5 papers), Respiratory viral infections research (5 papers), Influenza Virus Research Studies (4 papers), Virus-based gene therapy research (2 papers), Immune Response and Inflammation (2 papers), Streptococcal Infections and Treatments (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Neonatal and Maternal Infections (2 papers). The work is most often cited by research in Epidemiology (326 citations), Virology (37 citations), Microbiology (42 citations), Immunology (128 citations) and Infectious Diseases (108 citations). Cathy Maes has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Geert Leroux‐Roels, Fien De Boever, Emmanuel Hanon, François Roman, Isabel Leroux‐Roels, Mamadou Dramé, Paul Gillard, Julie Willekens, Frédéric Clément and Marcelle Van Mechelen. Their work appears in journals such as Vaccine, Clinical and Vaccine Immunology, Clinical Infectious Diseases, Frontiers in Immunology and Vaccines.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Cathy Maes

Impact in

Papers in i

In The Last Decade

Cathy Maes

Peers

Countries citing papers authored by Cathy Maes

Fields of papers citing papers by Cathy Maes

All Works

About Cathy Maes

Explore authors with similar magnitude of impact

Papers in